Nephros Inc (NEPH)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$4.06-2.87%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · NEPH
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 20.7 | 18.8 | 14.2 | 14.2 | 10.0 | 10.2 | 8.6 | 10.3 | 5.7 | 3.8 | 2.3 | 1.9 | 1.7 | 1.7 | 1.8 | 2.2 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 3.8 | 2.3 | 1.9 | 1.7 | 1.7 | 1.8 | 2.2 |
| Cost of Revenues | 8.0 | 7.2 | 5.4 | 5.8 | 5.2 | 4.6 | 3.6 | 4.3 | 2.5 | — | — | — | — | — | — | — |
| Gross Profit | 12.7 | 11.6 | 8.7 | 8.4 | 4.7 | 5.6 | 4.9 | 6.1 | 3.2 | 2.3 | 1.3 | 1.1 | 1.2 | 0.8 | 1.1 | 0.9 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 9.5 | 9.0 | 7.7 | 8.9 | 7.6 | 7.2 | 6.5 | 6.1 | 4.5 | 3.3 | 2.9 | 3.4 | 2.9 | 3.1 | 3.6 | 2.6 |
| R&D Expenses | 1.4 | 1.3 | 0.9 | 0.9 | 1.3 | 1.5 | 2.8 | 3.1 | — | — | — | — | — | — | — | — |
| Operating Income | 1.6 | 1.1 | 0.0 | (1.6) | (4.3) | (3.3) | (4.3) | (3.2) | (3.0) | (2.2) | (2.9) | (3.4) | (2.7) | (3.3) | (3.3) | (2.3) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.0 | 0.5 | 0.4 | 0.0 | 0.0 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | — | — | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | 0.2 | 0.3 | 0.2 | — | — | 0.4 | 0.0 | 0.0 |
| Other Non-Operating Income / Expenses | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.5 | (0.3) | — | — | — | — | — | — | — | — | — |
| Asset Writedown | — | — | — | — | 1.0 | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | 1.2 | 0.1 | (1.6) | — | — | (4.5) | (3.4) | (3.4) | (2.6) | — | — | — | — | — | — |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | (0.2) | (0.1) | (1.8) | — | — | — | — | — | — |
| Earnings from Continuing Operations | 1.7 | 1.2 | 0.1 | (1.6) | (4.3) | (2.8) | — | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | 0.3 | 0.2 | — | 0.2 | 0.1 | — | — | — | — | — | — | — |
| Net Income | 1.7 | 1.2 | 0.1 | (1.6) | (7.1) | (3.9) | (4.5) | (3.2) | (3.4) | (0.8) | (3.0) | (3.1) | (7.4) | 1.3 | (6.6) | (7.0) |
| Per Share | ||||||||||||||||
| Basic EPS | 0.16 | 0.11 | 0.01 | (0.15) | (0.73) | (0.41) | — | — | — | — | — | — | (0.31) | — | — | — |
| Diluted EPS | 0.16 | 0.11 | 0.01 | (0.15) | (0.73) | — | — | — | — | — | — | — | (0.31) | — | — | — |
| Revenue per Share | 1.86 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 10.9 | 10.6 | 10.5 | 10.4 | 10.3 | 10.0 | — | — | — | — | — | — | 23.8 | — | — | — |
| Diluted Weighted Avg Shares | 11.1 | 11.0 | 10.6 | 10.4 | 10.3 | — | — | — | — | — | — | — | 23.8 | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | 1.3 | 0.1 | (1.4) | (4.1) | (3.1) | (4.1) | (3.0) | (2.9) | (2.0) | (2.6) | (3.2) | (2.5) | (3.1) | (3.2) | — |
| EBIT | 1.6 | 1.1 | 0.0 | (1.6) | (4.3) | (3.3) | (4.3) | (3.2) | (3.0) | (2.2) | (2.9) | (3.4) | (2.7) | (3.3) | (3.3) | (2.3) |
| Effective Tax Rate | — | — | — | 0.0% | — | — | — | 6.6% | 2.7% | 68.9% | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.